Antonio Mas
Antonio Mas
Verified email at uclm.es
Title
Cited by
Cited by
Year
Interferon α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus
V Soriano, J Garcia-Samaniego, R Bravo, J Gonzalez, A Castro, J Castilla, ...
Clinical infectious diseases 23 (3), 585, 1996
2141996
Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance
A Mas, M Parera, C Briones, V Soriano, MA Martínez, E Domingo, ...
The EMBO journal 19 (21), 5752-5761, 2000
1192000
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1
ME Quiñones-Mateu, JL Albright, A Mas, V Soriano, EJ Arts
Journal of virology 72 (11), 9002-9015, 1998
941998
Unfinished stories on viral quasispecies and Darwinian views of evolution.
A Más, C López-Galíndez, I Cacho, J Gómez, MA Martínez
Journal of molecular biology 397 (4), 865, 2010
912010
Host deadenylation-dependent mRNA decapping factors are required for a key step in brome mosaic virus RNA replication
A Mas, I Alves-Rodrigues, A Noueiry, P Ahlquist, J Díez
Journal of virology 80 (1), 246-251, 2006
762006
Quasispecies as a matter of fact: viruses and beyond
S Ojosnegros, C Perales, A Mas, E Domingo
Virus research 162 (1), 203-215, 2011
592011
Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain EFFECT OF MUTATIONS …
T Matamoros, S Franco, BM Vázquez-Álvarez, A Mas, MÁ Martínez, ...
Journal of Biological Chemistry 279 (23), 24569-24577, 2004
542004
Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors
A Mas, BM Vázquez-Álvarez, E Domingo, L Menéndez-Arias
Journal of molecular biology 323 (2), 181-197, 2002
542002
Virus population dynamics, fitness variations and the control of viral disease: an update
E Domingo, A Mas, E Yuste, N Pariente, S Sierra, M Gutiérrez-Rivas, ...
Progress in drug research, 77-115, 2001
522001
LSm1-7 complexes bind to specific sites in viral RNA genomes and regulate their translation and replication
RP Galão, A Chari, I Alves-Rodrigues, D Lobão, A Mas, C Kambach, ...
Rna 16 (4), 817-827, 2010
452010
First Case of HIV‐1 Group O Infection in Spain
V Soriano, M Gutierrez, G García‐Lerma, O Aguilera, A Mas, R Bravo, ...
Vox sanguinis 71 (1), 66-66, 1996
451996
Hepatitis E Virus in Industrialized Countries: The Silent Threat
P Clemente-Casares, C Ramos-Romero, E Ramirez-Gonzalez, A Mas
BioMed research international 2016, 2016
442016
Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
ML Romiti, C Colognesi, C Cancrini, A Mas, M Berrino, F Salvatori, ...
Molecular Medicine 6 (1), 28, 2000
412000
LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression
ME Quiñones-Mateu, A Mas, T Lain de Lera, V Soriano, J Alcamí, ...
Virus research 57 (1), 11-20, 1998
411998
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance
J García-Cano, G Ambroise, R Pascual-Serra, MC Carrión, ...
Oncotarget 6 (17), 15551, 2015
392015
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse …
ME Quiñones-Mateu, M Tadele, M Parera, A Mas, J Weber, HR Rangel, ...
Journal of virology 76 (20), 10546-10552, 2002
392002
Functional characterization of chimeric reverse transcriptases with polypeptide subunits of highly divergent HIV-1 group M and O strains
L Menéndez-Arias, A Abraha, ME Quiñones-Mateu, A Mas, MJ Camarasa, ...
Journal of Biological Chemistry 276 (29), 27470-27479, 2001
372001
Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy
C Briones, A Mas, G Gómez-Mariano, C Altisent, L Menéndez-Arias, ...
Virus research 66 (1), 13-26, 2000
352000
Highly heterogeneous mutation rates in the hepatitis C virus genome
R Geller, Ú Estada, JB Peris, I Andreu, JV Bou, R Garijo, JM Cuevas, ...
Nature Microbiology, 16045, 2016
312016
Highly heterogeneous mutation rates in the hepatitis C virus genome
JM Cuevas, R Sabariegos, A Mas, R Sanjuán
31*2016
The system can't perform the operation now. Try again later.
Articles 1–20